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1. Introduction
The European Cystic Fibrosis Thematic Network is a
project approved under the fifth framework program from
the European Union. The philosophy of the network is
based on the need for closer interactions between the patient
organisations and the clinical profession as well as those
involved in fundamental research on CF [1].
In the context of this Cystic Fibrosis European Network,
questions were raised about the recommended policies for
the use of cells from cystic fibrosis patients for CF research
and quality control. The legal and ethical workgroup of the
Project therefore proposed to draft a consent form that
would integrate the legal and ethical requirements for the
use of human biological materials.
A meeting with the researchers of the Center for Human
Genetics at the University of Leuven quickly made it clear
that the cells that were to be removed from the CF patients
(enrolled as human subjects in a research protocol) would
not only be used for specific CF research and quality control
but would also be stored for later research purposes. The
consent form would therefore have to deal with broader
issues than those of human subjects research only. Ques-
tions on the secondary (further) use of stored human
biological materials also had to be answered.
A draft version of the consent form was presented at a
meeting with representatives of national and international
CF patient organisations in Leuven in 2001. After adapta-
tion based on some of the remarks, it was sent to seven
national CF associations for further comments [2]. These
comments have been thoroughly discussed and integrated in
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ask human subjects (CF patients) for consent to the (further)
use of their cells removed in the context of a research
protocol. The cells are removed specifically for CF research
purposes, but the subjects are also asked to consent to the
use of the cells for other (future) purposes. The consent form
traditionally presented to research subjects therefore had to
be adapted [3]. Consent is not only a prerequisite for human
subjects to participate in research, consent is also necessary
to use stored human biological materials for research
purposes [4].
Only patients 16 years and older are considered in the
consent form because there is still much uncertainty on the
legal conditions surrounding consent from minors for the
use of their cells and tissues for research purposes. [5]
Presumably, the proxy consent given by parents on behalf of
a minor could be ratified or withdrawn by the subject when
he/she becomes an adult, in accordance with the provision
given to adult donors (Information Leaflet, statement 8) but
this has not been tested in the courts.
The choices made throughout this consent form and the
legal arguments upon which these choices were based will
not be analysed in this article, this would exceed its scope,
which is to briefly present the consent form. An analysis of
the underlying legal arguments for the need to ask consent
and a description of the international background to the
research use of (stored) human biological materials can be
consulted [6]. We hope this information leaflet and consent
form offer some useful ideas to facilitate research on human
biological materials while respecting the rights of patients.
The consent form is written in the context of the CF
network project and is not adjusted to specific regulation
different European countries might have. It can serve as a
model for use in other projects, if reviewed by the local
ethics committee.
INFORMATION LEAFLET
INFORMATION PRECEDING THE REMOVAL,
PRESERVATION AND USE OF HUMAN CELLS FOR
RESEARCH AND/OR QUALITY ASSESSMENT
This information leaflet gives you information to help
you decide whether you want a sample of your cells to be
removed, preserved and used for medical research and/or
quality assessment. It will inform you on what will or could
happen, now and in the future, with your biological material
and how your privacy will be guaranteed. If you have anyed by Elsevier B.V. All rights reserved.
Correspondence198question, do not hesitate to contact your treating physician
or the Centre for Human Genetics, Campus Gasthuisberg,
Herestraat 41, 3000 Leuven, Tel. no. 016-34-58-81.
1. Use of human cells for research and/or quality
assessment
a. Research
You are asked to supply a sample of cells (for example
a blood sample) to be used for research/quality assessment.
No direct benefits for yourself can be promised from your
participation to this research. Research on the genetic
condition you inherited (mucoviscidosis or CF) could
however be of importance for other persons, who are
tested for or who suffer from the same disease and for
the understanding and treatment of genetic diseases in the
future. Your sample of biological material is not only
important to conduct scientific research on cystic fibrosis,
but it could also be essential for research on other (genetic)
diseases or research done to understand the functioning of
cells. We cannot predict all possible future tests which may
be developed as our understanding grows, so we cannot
give you more precise information on its nature at this
moment. We therefore offer you the option either to
consent only to CF research and quality control, or to
consent to other research on the condition that you receive
extra information on the nature of this latter research
before it is done. You may also choose to donate your
sample for future medical research without requiring to be
notified.
b. Quality control
Furthermore, your biological materials can be used for
quality assessment to ensure quality control of laboratory
DNA-tests. Your sample of biological material or the cell
lines derived from it will make it possible to assess and
improve the quality of CF diagnostic tests in a large number
of laboratories in Europe and other continents. The need to
assess regularly the quality of the diagnostic tests follows
from the fact that new methods and techniques are con-
stantly being introduced in the diagnostic labs. This requires
that these methods have to be validated first with samples
containing known mutations. In addition regular participa-
tion in external quality assessments will identify unexpected
errors in the laboratory procedures. Such errors can serious-
ly affect the quality of the results communicated to the
families. Therefore, it is important that such errors can be
detected.
The DNA that is extracted from your cells can also be
used to determine all possible variants in the composition of
your disease gene. In this way, an international DNA
standard for the gene can be obtained, which can be used
by all laboratories in the world in quality assessments as
described above.2. Removal of the cells
A sample of your cells (usually a blood sample) will be
taken, free of charge, by your general practitioner or
specialist in the usual way. This sample will be forwarded
to our laboratory.
3. Creation of cell lines
Cells obtained from your body may be used to establish a
cell line. This means that it will be possible to preserve your
biological material for a long time (in principle for an
indefinite period). This cell line creates an inexhaustible
source of DNA that can be used for quality assessment and
for scientific research in the future. Cell lines may be useful
because of the characteristics of the cells and/or the products
they may produce.
4. Supply to third parties of the cells or cell lines
created by using your sample
The cells and cell lines may be supplied in the future to
third parties (other researchers, international institutions
collecting cell lines). The purpose of this will always be the
use of them for scientific research or for quality assessment.
It is possible that the requesting researcher will be asked
to pay a contribution to the costs (costs for processing in the
lab, mailing costs) if the number of requests for such cell
lines should increase. Any personal financial profit for the
researchers is excluded.
The decision to supply a cell line to another research
institution or organisation will be evaluated by a supervisory
board specifically set up for this purpose. For the University
of Leuven, this supervisory board is composed by researchers
of the Center of Human Genetics, the Center of Biomedical
Ethics and Law and representatives of the patients’ organ-
isations. It will evaluate every request for a cell line from a
medical, ethical and legal point of view. It also will see to it
that the contribution paid by the requesting party will be used
only for research purposes and that your privacy is protected.
5. Protection of your privacy
During the quality assessment, the CF research as well as
during other scientific research by third parties for which
your biological material is used, your identity will always
remain unknown to the researchers. This is especially the
case when cell lines are supplied to third parties for
scientific research or quality control. This is done in order
to protect your privacy.
In practice, we will proceed as follows: during the
research in Leuven, your biological material will only be
identifiable in an indirect way. This means that your
biological material will be given a code (for instance, a
combination of letters and figures) that refers to your
personal data (name, sex, age, etc.). Identifying information
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itself. This code will be attributed by an administrative unit
within the Centre for Human Genetics (thus not by the
researchers of the Centre). The key of the code makes it
possible to link the sample to your identity. This key will
never be communicated to the researcher. This makes it
impossible for any researcher to know whose human bio-
logical material he is using. The key will remain in the
hands of the above-mentioned supervisory board.
When your cells leave Leuven, the code will be removed.
There will be no possibility for the third party to link the
cells to your identity.
6. New findings
Except when your cells are supplied to third parties, they
will not be completely anonymised (i.e. they will still have a
code). This is necessary for laboratory identification of the
sample and to avoid duplicating tests, but also because it
may be necessary to contact you if the research reveals new
information concerning your health status. This could be
information about your present as well as your future health
(for instance, information about an illness which for the
moment still has not got an appropriate treatment). We ask
you to indicate on the consent form whether or not you want
to be notified about significant new findings concerning
your health status. You will only be contacted if you indicate
on the consent form that you want to be informed, by the
doctor who has taken your biological sample.
7. Inventions, patents and commercial applications
It is conceivable that the research making use of your
cells could possibly lead to medical (biotechnological)
inventions. In order to legally protect these inventions, it
will be necessary to apply for patent protection. If an
invention is patented, its owner has an exclusive right to
exploit the invention during 20 years. Other people who
want to make use of the invention have to obtain a license
and have to pay for it. We ask your consent in order to be
able to apply for a patent, in case such an opportunity arises,
for any invention resulting from the research making use of
your biological material.
Moreover, it may be possible that that this invention
leads to industrial or commercial applications, for instance,
the development of a new medicine or a diagnostic kit. The
financial profits that derive from these applications as well
as from the licenses to make use of the invention, will for a
considerable part be re-invested in scientific research on CF.
You cannot claim any of these profits.
8. Withdrawal of the consent—destruction of human
biological materials
The consent you give to remove, preserve and use your
cells can be withdrawn at any time in the future. When youwithdraw your consent, you may also request that your
sample will be destroyed. This destruction will not be
possible if your cells have already been anonymised, because
in that case we cannot link them any more to your identity.
If your cells are already used in a research protocol, the
withdrawal of your consent (and the request to destruction)
can only have effect as from the ending of this research.
CONSENT FORM TO REMOVE, PRESERVE AND
USE HUMAN CELLS FOR RESEARCH AND/OR
QUALITY ASSESSMENT
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (last name and first
name) have read and understood the accompanying infor-
mation. I understand the nature and purposes of the scien-
tific research and quality assessment that will be performed
with my cells. I understand that they can be supplied to third
parties in a way that will protect my privacy.
I have had the opportunity to ask any question regarding
the use of my cells for scientific research and/or quality
assessment and I confirm that all my questions have been
answered in a satisfactory way.
I have been informed that my identity will be kept secret
from the researchers and that the identification of the cells
can only be done through a unique code that will remain in
the hands of the supervisory board.
I am aware that the original cells will not be destroyed and
will be preserved for research in the future unless I withdraw
my consent and request explicitly for their destruction.
I understand that I will not receive any financial remu-
neration for participating and that financial profits derived
from industrial or commercial applications will for a con-
siderable part be re-invested in scientific research on CF.
Herewith I give my explicit, informed and free consent
for (cross out whatever does not apply):
1. the use of my cells for:
a. quality assessment of CF-diagnosis
b. quality assessment and CF research
c. quality assessment, CF research and other (genetic)
research on condition that I will get more information
about this other research in advance
d. quality assessment, CF research and other (genetic)
research
2. the supply of cell lines to third parties
3. the possible application for patents for inventions for
which my cells have been used
4. the possible development of commercial and industrial
applications of these inventions
I wish/I do not wish (delete what is not applicable) to be
contacted if, in the course of the above-mentioned scientific
research and/or quality assessment during which my cells
have been used, new information is revealed concerning my
present or future health status.
Correspondence200This consent form has been made in three authentic
copies of which I received one.
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